2Cushman M.Epidemiology and risk factors for venous thrombosis.Semin Hematol,2007,44:62-69.
3Spencer FA,Emery C,Lessard D,et al.The Worcester venous thromboembolism study:a population-based study of the clinical epidemiology of venous thromboembolism.J Gen Intern Med,2006,21:722-727.
4Cohen AT,Agnelli G,Anderson FA,et al.Venous thromboembolism(VTE) in Europe.The number of VTE events and associated morbidity and mortality.Thromb Haemost,2007,98:756-764.
5Beckers MM,Ruven H J,Haas FJ,et al.Single nucleotide polymorphisms in inflammation-related genes are associated with venous thromboembolism.Eur J Intern Med,2010,21:289-292.
6Gohil R,Peck G,Sharma P,et al.The genetics of venous thromboembolism.A recta-analysis involving approximately 120,000 cases and 180,000 controls.Thromb Haemost,2009,102:360-370.
3Nosaka M,Ishida Y,Kimura A,et al.Absence of IFN-r accelerates thrombus resolution through enhanced MMP-9 and VEGF expression in mice[J].J Clin Invest,2011,121(7):2911-2920.
4Vedantham S.Deep venous thtombosis:the opportunity at hand AJR[J].AJR Am J Roentgenol,2009,193(4):922-927.
6Andereon FA Jr,Spencer FA.Risk factors for venous thromboembolism[J].Circulation,2003,107(23 Suppl 1):S9-16.
7Shorr AF,Jackson WL,Shemer JH,et al.Differences between low-mole-cular-weight and unfractionated heparin for venous thromboembo-lism prevention following ischemic stroke:ametaanalysis[J].Chest,2008,133(1):149-155.
